Harvard Bioscience Inc
HBIO· Nasdaq
HBIOHarvard Bioscience Inc
Released Mar 12, 2026, before the open
10-K filed Mar 13, 2026, 72 days after period end · 0001171843-26-001548
derived · Computed from the longer spans the company filed.
| Metric | Q4 2025dderived from reported figures | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures |
|---|---|---|---|---|
| Revenue | $23.74M | $24.56M | $28.15M | $28.43M |
| Net Income | -$2.85M |
Harvard Bioscience Inc · CIK 1123494 · Engraved from SEC EDGAR
| $18.00K |
| -$1.82M |
| -$1.67M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
